Oncology News Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test Bethlehem, PA – May 14, 2024 – Saladax Biomedical, Inc. (Saladax) is pleased to announce…SWBR Inc.June 5, 2024
Oncology News Personalized Medicine Initiatives Written by: Salvatore J. Salamone, Ph.D. Saladax Biomedical President and CEO Without Personalized Dosing, There Is…John BuckleyFebruary 3, 2023
Oncology News Oncology, Pharmacology, Therapeutic Drug Monitoring & Personalized Medicine Pharmacology describes pharmacokinetics (PK) - what the body does to the drug and pharmacodynamics (PD)…John BuckleyFebruary 3, 2023
Corporate News CEO Sal Salamone Honored with International Award for his Work in the Life Sciences Article By Nicole Radzievich Mertz, originally posted at lehighvalley.org Dr. Salvatore Salamone, founder of Saladax…John BuckleyNovember 30, 2021
Corporate News Saladax Biomedical Announces Salvatore J. Salamone, Ph.D. Received the Prestigious Dr. C.E. Pippenger Award BETHLEHEM, Pa.--(BUSINESS WIRE)--Salvatore J. Salamone, Ph.D. received the prestigious Dr. C.E. Pippenger Award at the…John BuckleySeptember 27, 2021
BusulfanOncology News Saladax Biomedical to Collaborate with AVROBIO on New High-Speed Diagnostic Assay Used with Busulfan Conditioning to Enable Widespread Commercialization of AVROBIO’s Proprietary Platform Globally Fully automated immunoassay kit designed to simplify and streamline busulfan therapeutic drug monitoring (TDM), potentially…John BuckleyMay 4, 2020